Patten Group’s DexCom DXCM Stock Holding History

Patten Group’s Portfolio DXCM Stock Details DXCM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	–	Sell	-300	Closed	-$6.15K	–	620
2016 Q3	$6.15K	Hold	300	–	–	﹤0.01%	514
2016 Q2	$5.95K	Hold	300	–	–	﹤0.01%	506
2016 Q1	$5.09K	Buy	+300	New	+$5.01K	﹤0.01%	532

Other funds holding DXCM

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

Brown Advisory Baltimore, Maryland $64.6B AUM 18.98% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return

JHIU

Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

FAM

Fred Alger Management New York $30B AUM 76.99% 1-Year Est. Return

Patten Group's DXCM Position: Q4 2016 in Review

Patten Group sold out of DexCom (DXCM) in Q4 2016, closing a stake of 300 shares — an estimated $6.15K sold.

Patten Group first reported a position in DXCM in Q1 2016 and held it in 3 quarters. The position peaked at $6.15K in Q3 2016. 316 funds tracked by Wall St. Rank hold DXCM as of Q4 2016.

Patten Group reported no remaining DexCom position as of Q4 2016 after selling out during the quarter.
Patten Group sold 300 DexCom shares in Q4 2016, an estimated $6.15K.
Patten Group first reported a position in DexCom in Q1 2016 and held it in 3 quarters.
Patten Group's DexCom position peaked at $6.15K in Q3 2016.
316 funds tracked by Wall St. Rank held DexCom as of Q4 2016.

Based on Patten Group's 13F filing for Q4 2016, filed 10 Feb 2017.